Maitane J. Asensio

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Impact of CD44 alternative splicing on the response to anticancer drugs.

Impact of CD44 alternative splicing on the response to anticancer drugs.

Journal: Biochemical pharmacology

Published: March 05, 2026

Impact of poly(rC)-binding protein 2 (PCBP2) on the malignant phenotype of cholangiocarcinoma.

Impact of poly(rC)-binding protein 2 (PCBP2) on the malignant phenotype of cholangiocarcinoma.

Journal: Biochemical pharmacology

Published: October 06, 2025

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

Journal: Hepatology (Baltimore, Md.)

Published: April 03, 2025

Relevance of transportome among the mechanisms of chemoresistance in hepatoblastoma.

Relevance of transportome among the mechanisms of chemoresistance in hepatoblastoma.

Journal: Biochemical pharmacology

Published: December 22, 2024

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas.

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas.

Journal: Journal of hepatology

Published: October 11, 2024

Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.

Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 04, 2024

Strategies to enhance the response of liver cancer to pharmacological treatments.

Strategies to enhance the response of liver cancer to pharmacological treatments.

Journal: American journal of physiology. Cell physiology

Published: May 06, 2024

Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition.

Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition.

Journal: Biochemical pharmacology

Published: January 18, 2024

Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma.

Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma.

Journal: Biochemical pharmacology

Published: May 23, 2023

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.

Journal: Cancers

Published: June 30, 2022

Impact of Alternative Splicing Variants on Liver Cancer Biology.

Impact of Alternative Splicing Variants on Liver Cancer Biology.

Journal: Cancers

Published: November 19, 2021

Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models.

Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models.

Journal: Pharmacological research

Published: November 12, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026